Tracking Progress Toward Tuberculosis Elimination in West Java (2017–2025)
DOI:
https://doi.org/10.59141/jiss.v7i8.2561Keywords:
tuberculosis, incidence rate, mortality rate, treatmentAbstract
Tuberculosis (TB) is a chronic infectious disease that remains a major global public health challenge caused by the bacterium Mycobacterium tuberculosis. This study aimed to analyze temporal trends in tuberculosis incidence rates (IR) and case fatality rates (CFR), as well as evaluate tuberculosis control strategies in West Java. This study employed an analytical descriptive method with a retrospective cohort study design. The temporal trend analysis showed that tuberculosis cases in West Java from 2017 to 2025 continued to increase significantly, accompanied by a rise in CFR. The tuberculosis elimination program in West Java has not yet achieved optimal effectiveness and continues to face various challenges. Therefore, improvements are needed through comprehensive epidemiological analysis, equitable access to quality healthcare services, strengthened early detection efforts, sustained cross-sectoral collaboration, and health education initiatives to increase public awareness and encourage the adoption of Clean and Healthy Living Behaviors (PHBS) to reduce tuberculosis transmission. The tuberculosis elimination program in West Java has not yet reached its expected targets, as indicated by the persistent increase in TB incidence and case fatality rates during the 2017–2025 period. Further strengthening of surveillance systems, prevention strategies, and healthcare interventions is required to accelerate progress toward tuberculosis elimination.
References
Agizew, T. B., Dememew, Z. G., Leta, T., Hiruy, N., Tesema, E., Abelti, E. A., Gebreyohannes, A., Alemayehu, Y. M., Omer, A. B., Suarez, P. G., Kassie, Y., Kassa, A., Gemechu, D., & Jerene, D. (2022). Prospects for tuberculosis elimination in Ethiopia: feasibility, challenges, and opportunities. Pan African Medical Journal, 43, 146. https://doi.org/10.11604/pamj.2022.43.146.35557
Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Boeree, M. J., & Bonnet, M. (2023). Tuberculosis preventive treatment: Clinical trial outcomes and programmatic impact in high TB/HIV burden countries. Lancet Infectious Diseases, 23(4), 478–491. https://doi.org/10.1016/S1473-3099(22)00728-5
Damen, M., B, G. C. A., Hifumi, T., & Nahid, P. (2025). Machine learning applications in tuberculosis diagnosis: A systematic review and meta-analysis. Frontiers in Medicine, 12, 1668254. https://doi.org/10.3389/fmed.2025.1668254
de, B. A. C., de, O. C. M. M., Unger, D. A. A., & S, B. M. J. de. (2022). Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update. Anais Brasileiros de Dermatologia, 97(2), 129–144. https://doi.org/10.1016/j.abd.2021.07.004
Donnan, E. J., Pett, J., Ulbricht, E., Massey, P. D., Sintchenko, V., & Marais, B. J. (2025). Progress and challenges to TB elimination in New South Wales, Australia. IJTLD Open, 2(6), 324–332. https://doi.org/10.5588/ijtldopen.24.0596
Juliana, R., Soleha, T. U., Yunianto, A. E., & Ismunandar, H. (2024). Pendekatan Diagnostik Berbasis Manifestasi, Pemeriksaan Klinis dan Tatalaksana Pada Tuberkulosis Paru. Medula, 14(9).
Kedthongma, W., Usaprom, S., & Phakdeekul, W. (2026). Community based interventions to improve tuberculosis treatment outcomes: A meta-analysis. MethodsX, 16. https://doi.org/10.1016/j.mex.2026.103893
Mardia, R. S., Yinke, B., Sinaga, M., Siagian, P., & Ashar, T. (2025). Risk Factor of Lost To Follow Up Treatment In Drug Sensitive Pulmonary TB Patients. IJHP (International Journal of Health and Pharmacy). https://ijhp.net
Ouaaziz, N. A., M, E. B., O, E. Y., Bejja, F., Taboz, Y., Soulaymani, A., & Quyou, A. (2024). Tuberculosis in southern Morocco: Retrospective analysis from 2006 to 2012. Tunisie Medicale, 102(5), 289–295. https://doi.org/10.62438/tunismed.v102i5.4825
Rabahi, M. F., R, D. S. J. J. L., Ferreira, A. C. G., Tannus-Silva, D. G. S., & Conde, M. B. (2017). Tuberculosis treatment. Jornal Brasileiro de Pneumologia, 43(6), 472–486. https://doi.org/10.1590/s1806-37562016000000388
Saputra, H., Asyary, A., Majid, R., & Salam, A. (2017). Management of Pulmonary Tuberculosis Patient with Their Culture Conversion Status in Kendari City, Province of Sulawesi Tenggara, Indonesia. Journal of Ultimate Public Health, 1(1), 18–23.
Shrivas, A., & Singh, S. (2025). Tuberculosis Diagnosis and Management: Recent Advances. Journal of Global Infectious Diseases, 17(1), 3–9. https://doi.org/10.4103/jgid.jgid_112_24
Simbolon, R. L., Simatupang, E. T. M., Yovi, I., & Fauzi, Z. A. (2025). Update on The Current Management of Drug-Resistant Tuberculosis (DR-TB). Indonesian Journal of Tropical and Infectious Disease, 13(2), 98–110. https://doi.org/10.20473/ijtid.v13i2.59075
Vasiliu, A., Martinez, L., Gupta, R. K., Hamada, Y., Ness, T., Kay, A., Bonnet, M., Sester, M., Kaufmann, S. H. E., Lange, C., & Mandalakas, A. M. (2024). Tuberculosis prevention: current strategies and future directions. Clinical Microbiology and Infection, 30(9), 1123–1130. https://doi.org/10.1016/j.cmi.2023.10.023
Wulandari, R., & Christin, M. C. M. (2024). Diagnosis, Management and Complication of Tuberculosis: A Comprehensive Systematic Review.
Yigci, D., Kayı, I., Demiroglu, Y. Z., Kutlu, M., Kılıcaslan, Z., & Ergonul, O. (2025). Tuberculosis in Turkiye: Epidemiological insights and recommendations for progress. European Journal of Clinical Microbiology and Infectious Diseases, 44(10), 2323–2330. https://doi.org/10.1007/s10096-025-05201-w
Zetola, N. M., Moonan, P. K., Click, E., Oeltmann, J. E., Basotli, J., Wen, X. J., Boyd, R., Tobias, J. L., Finlay, A., & Modongo, C. (2021). Population based geospatial and molecular epidemiologic study of tuberculosis transmission dynamics, Botswana, 2012–2016. Emerging Infectious Diseases, 27(3), 835–844. https://doi.org/10.3201/eid2703.203840
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Hermawan Saputra, Siti Maryati Puspita Sari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
